Adverum Biotechnologies, Inc.Adverum Biotechnologies, Inc.Adverum Biotechnologies, Inc.

Adverum Biotechnologies, Inc.

No trades
See on Supercharts
Market capitalization
‪231.42 M‬USD
−11.62USD
‪−117.17 M‬USD
‪3.60 M‬USD
‪14.98 M‬
Beta (1Y)
1.50

About Adverum Biotechnologies, Inc.

CEO
Laurent Fischer
Headquarters
Redwood City
Employees (FY)
121
Founded
2006
ISIN
US00773U2078
FIGI
BBG006D9MR17
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ADVM is 11.17 USD — it has increased by 0.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Adverum Biotechnologies, Inc. stocks are traded under the ticker ADVM.
Adverum Biotechnologies, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ADVM stock is 3.39% volatile and has beta coefficient of 1.50. Check out the list of the most volatile stocks — is Adverum Biotechnologies, Inc. there?
One year price forecast for Adverum Biotechnologies, Inc. has a max estimate of 60.00 USD and a min estimate of 20.00 USD.
ADVM earnings for the last quarter are −3.30 USD per share, whereas the estimation was −3.15 USD resulting in a −4.69% surprise. The estimated earnings for the next quarter are −3.36 USD per share. See more details about Adverum Biotechnologies, Inc. earnings.
Adverum Biotechnologies, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪76.67 K‬ USD. In the next quarter revenue is expected to reach ‪92.00 K‬ USD.
Yes, you can track Adverum Biotechnologies, Inc. financials in yearly and quarterly reports right on TradingView.
ADVM stock has fallen by 6.53% compared to the previous week, the month change is a 30.19% fall, over the last year Adverum Biotechnologies, Inc. has showed a 21.41% increase.
ADVM net income for the last quarter is ‪−23.71 M‬ USD, while the quarter before that showed ‪−32.88 M‬ USD of net income which accounts for 27.89% change. Track more Adverum Biotechnologies, Inc. financial stats to get the full picture.
Today Adverum Biotechnologies, Inc. has the market capitalization of ‪231.42 M‬, it has decreased by 6.12% over the last week.
No, ADVM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ADVM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Adverum Biotechnologies, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ADVM reached its all-time high on Jan 8, 2015 with the price of 624.80 USD, and its all-time low was 5.31 USD and was reached on Dec 27, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 121.00 employees. See our rating of the largest employees — is Adverum Biotechnologies, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Adverum Biotechnologies, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Adverum Biotechnologies, Inc. stock shows the sell signal. See more of Adverum Biotechnologies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Adverum Biotechnologies, Inc. future price: according to them, ADVM price has a max estimate of 60.00 USD and a min estimate of 20.00 USD. Read a more detailed Adverum Biotechnologies, Inc. forecast: see what analysts think of Adverum Biotechnologies, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Adverum Biotechnologies, Inc. EBITDA is ‪−111.21 M‬ USD, and current EBITDA margin is ‪−3.28 K‬%. See more stats in Adverum Biotechnologies, Inc. financial statements.